Netflix, Inc. (NASDAQ: NFLX) shares gained 7.1% on Wednesday after the company reported better-than-expected subscriber losses in the second quarter and detailed plans to launch a new, low-cost, ad-supported subscription tier.
Chardan Research initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) with a Buy rating and a price target of $29 and Dyne Therapeutics Inc (NASDAQ:DYN) with…
Wells Fargo analyst Gary Mobley reiterated an Overweight rating and $170 price target on Silicon Laboratories, Inc (NASDAQ:SLAB). Mobley expected his FY22-FY24 revenue…
RBC Capital analyst Brad Erickson summarized the key debates heading into the Q2 internet earnings season
While recent stories suggest fluid consumer trends, his SMB checks since last earnings suggested meaningful, proactive, downward SMB spending decisions to which these companies have exposure.